Abstract
Patients receiving spinal cord stimulation (SCS) therapy require frequent reprogramming following device implantation to achieve optimal pain management and commonly encounter therapy disruptions.1-3 Delays scheduling in-clinic visits are common and may extend periods of pain relapse and contribute to worsening outcomes.4,5 Further, evidence suggests pain intensity reported during in-clinic assessments may be inconsistent with at-home daily reports, and may not fully reflect SCS patient experience in real-world settings.6,7 The BENEFIT-03 Study (NCT04683718) is designed to evaluate the safety and effectiveness of an implantable SCS system with automated remote device monitoring, remote programming and multiphase stimulation.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Neuromodulation: Technology at the Neural Interface
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
